Miles Linde

7PUBLICATIONS
65CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 06, 2026
Modulating AP-1 enables CAR T cells to establish an intratumoral stemlike reservoir and overcomes resistance to PD-1 blockade.

Andrew J Snyder, Sarah M Garrison, Mitchell G Kluesner

|Jan 23, 2024
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation.

Niklas Landberg, Thomas Köhnke, Yang Feng

|Dec 13, 2023
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation.

Niklas Landberg, Thomas Köhnke, Yang Feng

|Mar 01, 2023
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.

Miles H Linde, Amy C Fan, Thomas Köhnke

|Jan 14, 2022
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.

Johanna Theruvath, Marie Menard, Benjamin A H Smith

Pageof 2